Cannabis use to reduce hospital mortality after a heart attack

November 20, 2019 0
heart-attack-cannabinoids-1200x800.jpg

Literature reports the potential effects that cannabis can have in cardiovascular complications.

Acute myocardial infarction (AMI) is more commonly known as a heart attack, which can lead to heart failure. In a multivariable analysis, it revealed that marijuana use can lead to an increased risk in AMI development, however, THC and CBD may have opposing effects. THC decreases in contractile force and coronary flow, while also inducing an increased frequency. On the other hand, CBD can increase contractile force and coronary flow, but it does not change the heart rate.

Investigations about mortality post AMI and medical cannabis

Moreover, a new study in 2018 was carried out on the relationship between patients who suffered a heart attack from 1994 – 2013 and the use of cannabis. The results showed a reduced mortality post AMI. An explanation to this can be a hint on the possible cardiac infarct preventative effects in cannabis. Although cannabis has this positive effect, consumers can still have an increased risk of mechanical ventilation after a heart attack.

Therefore, the results show clear evidence that cannabis is not associated with an increased risk, as opposed to the assumptions that it can cause unfavourable effects after a heart attack.

Source https://www.kalapa-clinic.com/en/cannabis-reduce-mortality-heart-attack/


Leave a Reply

Your email address will not be published. Required fields are marked *


Logo Can Pharma SVG

CanPharma has a pharmaceutical wholesale permission according to §52a of the German Medicines Act, as well as a license to handle narcotics in the meaning of §3 of the German narcotics legislation. Furthermore, CanPharma has a GDP-certified quality assurance system.

MEMBER OF

footerlogos

OFFICES

CanPharma GmbH
Wiesbadener Str. 29
16515 Oranienburg
Germany

CanPharma Portugal
Rua João Fernandes
Lavrador 1 – Sala 6 2825-
132 Vila Nova de Caparica
Portugal

REPRESENTATIVE OFFICES

Berlin
Neue Kantstraße 18
14057 Berlin
Germany

Barcelona
Gran de Gràcia 15, 1-1
08012 Barcelona
Spain